The latest announcement is out from Shanghai Fudan Zhangjiang Bio Pharmaceutical Co ( (HK:1349) ).
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. announced a final cash dividend of RMB 0.03 per share for the financial year ending December 31, 2024, with a payment date set for August 25, 2025. The announcement includes details on the withholding tax rates applicable to different types of shareholders, which may impact the net dividend received by investors. This update reflects the company’s commitment to returning value to its shareholders and may influence investor sentiment positively.
More about Shanghai Fudan Zhangjiang Bio Pharmaceutical Co
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. operates in the biopharmaceutical industry, focusing on the development and commercialization of innovative drugs. The company is primarily engaged in the research and production of pharmaceuticals, targeting various medical needs.
For an in-depth examination of 1349 stock, go to TipRanks’ Stock Analysis page.